{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T01:05:09Z","timestamp":1759799109430,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Obesity is a known risk factor for autoimmune disorders. Chronic steroid treatment among these patients poses greater surgical risk, but biological\/immunomodulating agents (BIA) have allowed for safer alternatives. The effects of BIA monotherapy on postoperative complications following metabolic\/bariatric surgery (MBS) have not been studied. We aimed to evaluate the effects of preoperative BIA use on post-metabolic\/bariatric surgery outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective matched-pair cohort study of patients who underwent bariatric surgery between 2012 and 2024. Patients were stratified into two groups: those with autoimmune disorders on BIA monotherapy vs matched controls. Patients were matched by age, BMI, and surgery type (Roux-en-Y gastric bypass [RYGB] vs vertical sleeve gastrectomy [VSG]). Paired T-tests were used to compare continuous variables. McNemar\u2019s test was used to compare dichotomous variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirty patients (15 per group) were included in the study. Sixty percent of patients underwent VSG. Among biologic monotherapy patients, 46.7% had rheumatoid arthritis, and 66.7% of BIA were TNF inhibitors. BIAs were used within 12\u00a0months of surgery, stopped 6\u00a0weeks prior to surgery, and resumed 6\u00a0weeks after surgery. Although there was no difference in preoperative comorbidities, BIA group had a significantly higher ASA status (100% with ASA 3) compared to controls (60.0% with ASA 3, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Postoperatively, there were no differences in wound complications (6.7% BIA vs. 0% control, <jats:italic>p<\/jats:italic>\u2009=\u20091.00) or readmissions (0% BIA vs 6.7% control, <jats:italic>p<\/jats:italic>\u2009=\u20091.00). There were no anastomotic leaks, VTE, or death in either group. Six-month postoperative weight loss was equal between groups: (50.7\u2009\u00b1\u200915.4%EWL BIA vs 53.4 <jats:inline-formula>\n                <jats:alternatives>\n                  <jats:tex-math>$$\\pm$$<\/jats:tex-math>\n                  <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mo>\u00b1<\/mml:mo>\n                  <\/mml:math>\n                <\/jats:alternatives>\n              <\/jats:inline-formula> 19.8%EWL control, <jats:italic>p<\/jats:italic>\u2009=\u20090.89; %TWL (19.7\u2009\u00b1\u20096.1 [15.1\u201323.8] vs. 21.2\u2009\u00b1\u20095.9 [16.9\u201327.6], <jats:italic>p<\/jats:italic>\u2009=\u20090.78).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite higher ASA status, patients on BIA did not have increased postoperative complications, and had similar weight loss to control patients after MBS. Our data suggests that when managed appropriately, patients on BIA have similar benefits from MBS without added risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00464-025-12046-z","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T18:59:44Z","timestamp":1755197984000},"page":"6828-6834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bias against biologics in bariatric surgery: is it justified?"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-3741","authenticated-orcid":false,"given":"Jerome C.","family":"Anyalebechi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Lyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shushmita M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"12046_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jacc.2024.06.008","volume":"84","author":"A Aminian","year":"2024","unstructured":"Aminian A, Wang L, Al Jabri A, Wilson R, Bena J, Milinovich A, Jin J, Heinzinger C, Pena-Orbea C, Foldvary-Schaefer N, Nissen SE, Mehra R (2024) Adverse cardiovascular outcomes in patients with obstructive sleep apnea and obesity: metabolic surgery vs usual care. J Am Coll Cardiol 84:1047\u20131060","journal-title":"J Am Coll Cardiol"},{"key":"12046_CR2","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.2337\/dc20-3023","volume":"44","author":"A Aminian","year":"2021","unstructured":"Aminian A, Wilson R, Zajichek A, Tu C, Wolski KE, Schauer PR, Kattan MW, Nissen SE, Brethauer SA (2021) Cardiovascular outcomes in patients with type 2 diabetes and obesity: comparison of gastric bypass, sleeve gastrectomy, and usual care. Diab Care 44:2552\u20132563","journal-title":"Diab Care"},{"issue":"248\u2013256","key":"12046_CR3","volume":"122","author":"H Buchwald","year":"2009","unstructured":"Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248\u2013256):e245","journal-title":"Am J Med"},{"key":"12046_CR4","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.surge.2022.04.008","volume":"21","author":"A Mian","year":"2023","unstructured":"Mian A, Khan S (2023) Systematic review: outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery. Surgeon 21:e71\u2013e77","journal-title":"Surgeon"},{"key":"12046_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","volume":"152","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Sorensen JA, Gislason GH, Knop FK, Skov L (2017) Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery. JAMA Surg 152:344\u2013349","journal-title":"JAMA Surg"},{"key":"12046_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ (2017) Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol 14:110\u2013121","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12046_CR7","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","volume":"122","author":"F Samad","year":"2013","unstructured":"Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415\u20133422","journal-title":"Blood"},{"key":"12046_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.soard.2023.10.006","volume":"20","author":"RM Mabeza","year":"2024","unstructured":"Mabeza RM, Vadlakonda A, Chervu N, Ebrahimian S, Sakowitz S, Yetasook A, Benharash P (2024) Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis. Surg Obes Relat Dis 20:146\u2013152","journal-title":"Surg Obes Relat Dis"},{"key":"12046_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/jcm14020402","volume":"14","author":"A Litmanovich","year":"2025","unstructured":"Litmanovich A, Yuval JB, Agostini ED, Orbach L, Kariv Y, Zemel M, Lahat G, Abu-Abeid A (2025) Outcomes of metabolic and bariatric surgery in patients with inflammatory bowel disease: a long-term retrospective analysis. J Clin Med 14:402","journal-title":"J Clin Med"},{"key":"12046_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11695-015-1909-y","volume":"26","author":"A Aminian","year":"2016","unstructured":"Aminian A, Andalib A, Ver MR, Corcelles R, Schauer PR, Brethauer SA (2016) Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg 26:1186\u20131190","journal-title":"Obes Surg"},{"key":"12046_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s11695-017-2955-4","volume":"28","author":"F Bazerbachi","year":"2018","unstructured":"Bazerbachi F, Sawas T, Vargas EJ, Haffar S, Deepak P, Kisiel JB, Loftus EV Jr, Abu Dayyeh BK (2018) Bariatric surgery is acceptably safe in obese inflammatory bowel disease patients: analysis of the nationwide inpatient sample. Obes Surg 28:1007\u20131014","journal-title":"Obes Surg"},{"key":"12046_CR12","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s11695-019-03995-1","volume":"29","author":"J Hefler","year":"2019","unstructured":"Hefler J, Dang J, Modasi A, Switzer N, Birch DW, Karmali S (2019) Effects of chronic corticosteroid and immunosuppressant use in patients undergoing bariatric surgery. Obes Surg 29:3309\u20133315","journal-title":"Obes Surg"},{"key":"12046_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s11695-022-06372-7","volume":"33","author":"J Maroun","year":"2023","unstructured":"Maroun J, Vahibe A, Shah M, Mundi MS, Acosta A, McKenzie TJ, Kellogg TA, Ghanem OM (2023) Impact of chronic immunosuppression on short-, mid-, and long-term bariatric surgery outcomes. Obes Surg 33:240\u2013246","journal-title":"Obes Surg"},{"key":"12046_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","volume":"103","author":"SC Manson","year":"2009","unstructured":"Manson SC, Brown RE, Cerulli A, Vidaurre CF (2009) The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 103:975\u2013994","journal-title":"Respir Med"},{"key":"12046_CR15","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","volume":"39","author":"JB Rice","year":"2017","unstructured":"Rice JB, White AG, Scarpati LM, Wan G, Nelson WW (2017) Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther 39:2216\u20132229","journal-title":"Clin Ther"},{"key":"12046_CR16","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/j.1572-0241.2008.01942.x","volume":"103","author":"V Subramanian","year":"2008","unstructured":"Subramanian V, Saxena S, Kang JY, Pollok RC (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103:2373\u20132381","journal-title":"Am J Gastroenterol"},{"key":"12046_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.surg.2018.12.016","volume":"165","author":"F Chouairi","year":"2019","unstructured":"Chouairi F, Torabi SJ, Mercier MR, Gabrick KS, Alperovich M (2019) Chronic steroid use as an independent risk factor for perioperative complications. Surgery 165:990\u2013995","journal-title":"Surgery"},{"key":"12046_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jdv.12997","volume":"30","author":"W Bakkour","year":"2016","unstructured":"Bakkour W, Purssell H, Chinoy H, Griffiths CE, Warren RB (2016) The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures. J Eur Acad Dermatol Venereol 30:86\u201391","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"12046_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.gastro.2022.03.057","volume":"163","author":"BL Cohen","year":"2022","unstructured":"Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE (2022) Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 163:204\u2013221","journal-title":"Gastroenterology"},{"key":"12046_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","volume":"83","author":"A Kuek","year":"2007","unstructured":"Kuek A, Hazleman BL, Ostor AJ (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83:251\u2013260","journal-title":"Postgrad Med J"},{"key":"12046_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMra1907607","volume":"385","author":"DC Baumgart","year":"2021","unstructured":"Baumgart DC, Le Berre C (2021) Newer biologic and small-molecule therapies for inflammatory bowel disease. N Engl J Med 385:1302\u20131315","journal-title":"N Engl J Med"},{"key":"12046_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.soard.2015.02.003","volume":"11","author":"SA Brethauer","year":"2015","unstructured":"Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S, Committee ACI (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 11:489\u2013506","journal-title":"Surg Obes Relat Dis"},{"key":"12046_CR23","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL (2017) Prevalence of obesity among adults and youth: United States, 2015\u20132016. NCHS Data Brief: 1\u20138"},{"key":"12046_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biologicals.2019.07.001","volume":"61","author":"K Kostev","year":"2019","unstructured":"Kostev K, Madelung M (2019) Prescription-based prevalence of biological therapy in patients with psoriasis, rheumatoid arthritis, and inflammatory bowel diseases. Biologicals 61:52\u201354","journal-title":"Biologicals"},{"key":"12046_CR25","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1007\/s00464-023-10158-y","volume":"37","author":"AJ Johns","year":"2023","unstructured":"Johns AJ, Luce MS, Kaneski MJ, Lowery RA, Jachniewicz B, Salas A, McCreary R, Russell RM, Lyo V, Ali MR, Ahmed SM (2023) The long weight: association between distressed communities index and long-term weight outcomes following bariatric surgery. Surg Endosc 37:7218\u20137225","journal-title":"Surg Endosc"},{"key":"12046_CR26","doi-asserted-by":"crossref","unstructured":"Belle SH, Berk PD, Chapman WH, Christian NJ, Courcoulas AP, Dakin GF, Flum DR, Horlick M, King WC, McCloskey CA, Mitchell JE, Patterson EJ, Pender JR, Steffen KJ, Thirlby RC, Wolfe BM, Yanovski SZ, Consortium L (2013) Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis. 9: 926-935","DOI":"10.1016\/j.soard.2013.01.023"},{"key":"12046_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.soard.2017.01.021","volume":"13","author":"R Sudan","year":"2017","unstructured":"Sudan R, Maciejewski ML, Wilk AR, Nguyen NT, Ponce J, Morton JM (2017) Comparative effectiveness of primary bariatric operations in the United States. Surg Obes Relat Dis 13:826\u2013834","journal-title":"Surg Obes Relat Dis"},{"key":"12046_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7326\/M17-2786","volume":"169","author":"D Arterburn","year":"2018","unstructured":"Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Williams N, Coleman KJ, Courcoulas A, Coley RY, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, McTigue KM, Collaborative PCBS (2018) Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med 169:741\u2013750","journal-title":"Ann Intern Med"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12046-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12046-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12046-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:05:02Z","timestamp":1759781102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12046-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["12046"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12046-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"type":"print","value":"0930-2794"},{"type":"electronic","value":"1432-2218"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Jerome Anyalebechi and Mr. Brian Howard have no conflicts of interest or financial ties to disclose. Drs. Shushmita Ahmed and Victoria Lyo had travel expenses to educational conferences paid for by Intuitive Surgical. Dr. Victoria Lyo received funding for separate research from the National institute of Health, Building Interdisciplinary Research Careers in Women's Health at UC Davis through Grant Number: 5K12HD051958 and is a member of the American Society for Metabolic & Bariatric Surgery (ASMBS) Research Committee and Board Member of the CA\/NV Chapter of the ASMBS. Dr. Mohamed Ali received funding for other research from the ASMBS Foundation, has received consulting fees from Stryker and Olympus, received travel support from Stryker, is on the DSMB for a University of Michigan NIH study, and is co-chair of the ASMBS Emerging Technology Committee, ASMBS liaison to the Fellowship Council Curriculum Committee, and is a member of the American Board of Surgery Bariatric FPD Exam Writing Group.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}